𝔖 Bobbio Scriptorium

✦ LIBER ✦

Harnessing the incretin system beyond glucose control: Potential cardiovascular benefits of GLP-1 receptor agonists in type 2 diabetes

✍ Scribed by B. Cariou

Book ID: 119227117
Publisher: Masson Editeur
Year: 2012
Tongue: French
Weight: 553 KB
Volume: 38
Category: Article
ISSN: 1262-3636
DOI: 10.1016/j.diabet.2012.04.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose-dependent effects of the once-daily

Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial

✍ R. E. Ratner; J. Rosenstock; G. Boka; on behalf of the DRI6012 Study Investigato 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)

✍ Y. Seino; K. W. Min; E. Niemoeller; A. Takami; on behalf of the EFC10887 GETGOAL 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB